Search for resources
Released by the EPO and the EUIPO, this study shows that companies which own at least one patent, registered design or trade mark generate on average 20% higher revenues per employee than companies which do not own any of those intellectual property rights (IPRs).
Tea with ASTP: Policies for Spin-out
Most KTOs work with the spin-out route as a way of commercialising inventions from our research institutions: there are different models and policies in place at different KTOs. Marjan Kraak (Head of Spin-Off Group, ETH Transfer at ETH Zurich) take us through ETH Zurich's models and processes.
The World Intellectual Property Indicators 2020 report covers 2019 data, predating the human and economic shock of the COVID-19 pandemic. What this year’s WIPI documents, however, is a strong foundation of IP activity that will serve as a base for new advancements as the pandemic subsides.
Tea with ASTP: Corporate Partnerships
Ben Soffer, Head of Corporate Partnerships Kings College London presents ouon Corporate Partnerships.The MedTech Accelerator will act as a vehicle for the commercialisation of MedTech innovations. The Accelerator will be set up as a limited company based on a shareholder agreement and, in parallel, the parties are looking to facilitate the creation of a venture fund. The Accelerator has the ambition to position itself as the best place in the UK for MedTech Innovation to flourish successfully.
Tea with ASTP: IP management strategies at the time of covid-19
The pandemic prompted universities and public research organisations to re-think their IP management strategies. Various open licenses have been developed granting free temporary access to IP rights to tackle the coronavirus crisis. Do IPRs represent a barrier to access innovation in times of health emergencies?
Tea with ASTP: Managing and valorising clinical data
Large healthcare datasets, Artificial Intelligence and Machine Learning can change the clinical innovation landscape. However, data access and valorisation cannot discount patients' rights; dealing with clinical data often represents a challenge for the collaboration between universities and research hospitals.